Synthesis and antimicrobial activity of new (4,4,4-trihalo-3-oxo-but-1- enyl)-carbamic acid ethyl esters, (4,4,4-trihalo-3-hydroxy-butyl)-carbamic acid ethyl esters, and 2-oxo-6-trihalomethyl-[1,3]oxazinane-3-carboxylic acid ethyl esters

Bioorganic and Medicinal Chemistry

Volumn 14, Issue 9, 2006, Pages 3174-3184

  Zanatta, Nilo ^a   Borchhardt, Deise M ^a   Alves, Sydney H ^a   Coelho, Helena S ^a   Squizani, Adriana M C ^a   Marchi, Tiago M ^a   Bonacorso, Helio G ^a   Martins, Marcos A P ^a  

^a FEDERAL UNIVERSITY OF SANTA MARIA   (Brazil)

Author keywords

1,3 Oxazinan 2 ones; Antimicrobial activity; Carbamates; Carbamic acid ethyl ester; MIC; Minimal inhibitory concentration

Indexed keywords

(4,4,4 TRICHLORO 1 METHYL 3 OXO BUT 1 ENYL)CARBAMIC ACID ETHYL ESTER; (4,4,4 TRICHLORO 3 OXO 1 PHENYL BUT 1 ENYL)CARBAMIC ACID ETHYL ESTER; (4,4,4 TRICHLORO 3 OXO BUT 1 ENYL)CARBAMIC ACID ETHYL ESTER; (4,4,4 TRIFLUORO 3 HYDROXY 1 METHYLBUTYL)CARBAMIC ACID ETHYL ESTER; (4,4,4 TRIFLUORO 3 HYDROXYBUTYL)CARBAMIC ACID ETHYL ESTER; (4,4,4 TRIFLUORO 3 OXO 1 BUT 1 ENYL)CARBAMIC ACID ETHYL ESTER; 2 OXO 4 (4 METHYLPHENYL) 6 TRICHLOROMETHYL[1,3]OXAZINANE 3 CARBOXYLIC ACID ETHYL ESTER; 2 OXO 4 (4 METHYLPHENYL) 6 TRIFLUOROMETHYL[1,3]OXAZINANE 3 CARBOXYLIC ACID ETHYL ESTER; 2 OXO 4 PHENYL 6 TRICHLOROMETHYL[1,3]OXAZINANE 3 CARBOXYLIC ACID ETHYL ESTER; 2 OXO 4 PHENYL 6 TRIFLUOROMETHYL[1,3]OXAZINANE 3 CARBOXYLIC ACID ETHYL ESTER; 2 OXO 6 TRICHLOROMETHYL[1,3]OXAZINANE 3 CARBOXYLIC ACID ETHYL ESTER; 2 OXO 6 TRIFLUOROMETHYL[1,3]OXAZINANE 3 CARBOXYLIC ACID ETHYL ESTER; 4 METHYL 2 OXO 6 TRICHLOROMETHYL[1,3]OXAZINANE 3 CARBOXYLIC ACID ETHYL ESTER; 4 METHYL 2 OXO 6 TRIFLUOROMETHYL[1,3]OXAZINANE 3 CARBOXYLIC ACID ETHYL ESTER; [4,4,4 TRICHLORO 1 (4 METHYLPHENYL) 3 OXO BUT 1 ENYL]CARBAMIC ACID ETHYL ESTER; [4,4,4 TRIFLUORO 1 (4 METHYLPHENYL) 3 OXO BUT 1 ENYL]CARBAMIC ACID ETHYL ESTER; [4,4,4 TRIFLUORO 3 HYDROXY 1 (4 METHYLPHENYL)BUTYL]CARBAMIC ACID ETHYL ESTER; AMPHOTERICIN; CARBAMIC ACID DERIVATIVE; ESTER DERIVATIVE; FLUCONAZOLE; IMIPENEM; KETONE DERIVATIVE; SODIUM BOROHYDRIDE; UNCLASSIFIED DRUG; URETHAN; URETHAN DERIVATIVE;

ALGA; ANTIMICROBIAL ACTIVITY; ARTICLE; BACTERIUM; CONTROLLED STUDY; CYCLIZATION; DRUG SYNTHESIS; FUNGUS; IN VITRO STUDY; MICHAEL ADDITION; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; YEAST;

ANTI-BACTERIAL AGENTS; CARBOXYLIC ACIDS; ESTERIFICATION; HYDROXYLATION; MAGNETIC RESONANCE SPECTROSCOPY; METHYLATION; MOLECULAR STRUCTURE; OXIDATION-REDUCTION; STRUCTURE-ACTIVITY RELATIONSHIP; TRANSITION TEMPERATURE;

ALGAE; BACTERIA (MICROORGANISMS); FUNGI; TRIFLUORO;

EID: 33644968198     PISSN: 09680896     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bmc.2005.12.031     Document Type: Article

References (38)

1. A. Espinel-Ingroff, T. White, and M.A. Pfaller Antifungal Agents and Susceptibility Tests P.R. Murray E.J. Baron M.A. Pfaller F.C. Tenover Manual of Clinical Microbiology 7th ed. 1999 ASM Press 1640 1652
2. J.H. Jorgensen, J.D. Turnidge, and J.A. Washington Antibacterial Susceptibility Tests: Dilution and Disk diffusion methods P.R. Murray E.J. Baron M.A. Pfaller F.C. Tenover R.H. Yolken Manual of Clinical Microbiology 7th ed. 1999 ASM Press 1526 1543
3. B.C.Q. Leimann, P.C.F. Monteiro, M. Lazéra, E.R.U. Candanoza, and B. Wanke Med. Mycol. 42 2004 95
4. J. Loeffler, and D.A. Stevens Clin. Infect. Dis. 30 2003 531 541
5. L.T. Phan, R.F. Clark, M. Rupp, Y.S. Or, D.T.W. Chu, and Z. Ma Org. Lett. 2 2000 2951
6. I. Iriepa, B. Gil-Alberdi, E. Gálvez, F.J. Villasante, J. Bellanato, and P. Carmona J. Mol. Struct. 482 1999 437
7. H.S. Kim, K.C. Kwon, K.S. Kim, and C.H. Lee Bioorg. Med. Chem. Lett. 11 2001 3065
8. R.F. Keyes, J.J. Carter, E.E. Englund, M.M. Daly, G.G. Stone, A.M. Nilius, and Z. Ma J. Med. Chem. 46 2003 1795
9. X. Sun, D.J. Zeckner, W.L. Current, R. Boyer, C. McMillian, N. Yumibe, and S.H. Chen Bioorg. Med. Chem. Lett. 11 2001 1875
10. T.C. Henninger, X. Xu, D. Abbanat, E.Z. Baum, B.D. Foleno, J.J. Hilliard, K. Bush, D.J. Hlasta, and M.J. Macielag Bioorg. Med. Chem. Lett. 14 2004 4495
11. J. Alexander, D.S. Bindra, J.D. Glass, M.A. Holahan, G.S. Reneyer, G.R. Sitko, M.T. Stranieri, R.F. Stupienski, H. Veerapanane, and J.J. Cook J. Med. Chem. 39 1996 480
12. P. Adams, and F.A. Baron Chem. Rev. 65 1965 567
13. M.R. Barbachyn, D.K. Hutchinson, S.J. Brickner, M.H. Cynamon, J.O. Kilburn, S.P. Klemens, S.E. Glickman, K.C. Grega, S.K. Hendges, D.S. Toops, C.W. Ford, and G.E. Zurenko J. Med. Chem. 39 1996 680
14. P. Lin, and J. Jiang Tetrahedron 56 2000 3635
15. J.T. Welch Tetrahedron 43 1987 3123
16. S.R. Cechin, M.R.C. Schetinger, N. Zanatta, C.C. Madruga, I.L. Pacholski, D.C. Flores, H.G. Bonacorso, M.A.P. Martins, and V.M. Morsch Chem. Res. Toxicol. 16 2003 1433
17. M.C.M. Godoy, M.R. Fighera, A.E. Flores, M.A. Rubin, M.R. Oliveira, N. Zanatta, M.A.P. Martins, H.G. Bonacorso, and C.F. Mello Eur. J. Pharmacol. 496 2004 93
18. F.R. Souza, V.T. Souza, V. Ratzlaff, L. Borges, M. Oliveira, H.G. Bonacorso, N. Zanatta, M.A.P. Martins, and C.F. Mello Eur. J. Pharmacol. 451 2002 141
19. P. Csomós, G. Bernáth, P. Sohár, A. Csámpai, N.D. Kimpe, and F. Fülöp Tetrahedron 57 2001 3175
20. J.R. Ella-Menye, V. Sharma, and G. Wang J. Org. Chem. 70 2005 463
21. A. Colla, G. Clar, M.A.P. Martins, S. Krimmer, and P. Fischer Synthesis 1991 483
22. N. Zanatta, A.M.C. Squizani, L. Fantinel, F.M. Nachtigal, H.G. Bonacorso, and M.A.P. Martins Synthesis 2002 2409
23. H.G. Bonacorso, A.P. Wentz, S.R.T. Bittencourt, L.M.L. Marques, N. Zanatta, and M.A.P. Martins Synth. Commun. 32 2002 335
24. H.G. Bonacorso, S.H.G. Duarte, N. Zanatta, and M.A.P. Martins Synthesis 2002 1037
25. M.G. Gorbunova, I.I. Gerus, and V.P. Kukhar Synthesis 1999 738
26. R.J. Andrew, and J.M. Mellor Tetrahedron 56 2000 7267
27. I.I. Gerus, M.G. Gorbunova, S.I. Vdovenko, Y.L. Yagupollskii, and V.P. Kukhar Chem. Heterocycl. Compd. 1991 1623
28. M.G. Gorbunova, I.I. Gerus, S.V. Galushko, and V.P. Kukhar Synthesis 1992 533
29. K. Takasu, N. Nishida, and M. Ihara Synlett 2004 1844
30. W. Schroth, and R. Spitzner Monatsh. Chem. 118 1987 1263
31. M.E. Pierce, R.L. Parsons, L.A. Radesca, Y.S. Lo, S. Silverman, J.R. Moore, Q. Islam, A. Choudhury, J.M.D. Fortunak, D. Nguyen, C. Luo, S.J. Morgan, W.P. Davis, P.N. Confalone, C. Chen, R.D. Tillyer, L. Frey, L. Tan, F. Xu, D. Zhao, A.S. Thompson, E.G. Corley, E.J.J. Grabowski, R. Reamer, and P.J. Reider J. Org. Chem. 63 1998 8536
32. B.B. Lohray, S. Baskaran, Y. Reddy, and S. Rao Tetrahedron Lett. 39 1998 6555
33. E. Heiner, and B. Foster Angew. Chem. 99 1987 922
34. S.M.A. Hashmi, M.I.M. Wazeer, M.S. Hussain, J.H. Reibenspies, H.P. Perzanowski, and Sk.A. Ali J. Chem. Soc., Perkin Trans. 2 1999 877
35. National Committee for Clinical Laboratory Standards, 2002. Reference method for broth dilution antifungal susceptibility testing of yeast: approved standard. NCCLS document M27-A2. Wayne, PA. National Committee for Clinical Laboratory Standards.
36. National Committee for Clinical Laboratory Standards, 2002. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically; approved standard; 5th ed. NCCLS document M7-A5, Wayne, PA. National Committee for Clinical Laboratory Standards.
37. N.H. Campanha, K.H. Neppelenbroek, D.M.P. Spolidoro, L.C. Spolidoro, and A.C. Pavarina Oral Dis. 11 2005 392
38. S.H. Alves, E.P. Milan, P. Sant'Anna, L.O. Oliveira, J.M. Santurio, and A.L. Colombo Diag. Microbiol. Infect. Dis. 43 2002 85